bet9九州网址

  • <kbd id="sdring" ><rt id="sdring" ><bdo id="sdring" ></bdo></rt></kbd>
  • <source id="sdring" ></source>

    <b id="sdring" ></b>
  • <b id="sdring" ><acronym id="sdring" ><meter id="sdring" ></meter></acronym></b>

        <del id="sdring" ></del>
        Log in
        E-mail
        Password
        Remember
        Forgot password ?
        Become a member for free
        Sign up
        Sign up
        New member
        Sign up for FREE
        New customer
        Discover our services
        Settings
        Settings
        Dynamic quotes 

        MarketScreener Homepage  >  Equities  >  Nasdaq  >  DexCom, Inc.    DXCM

        DEXCOM, INC.

        (DXCM)
          Report  
         SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
        Quotes 5-day view   Delayed Quote. Delayed Nasdaq
        11/05/2019 11/06/2019 11/07/2019 11/08/2019 11/11/2019 Date
        153.56(c) 153.12(c) 194.7(c) 198.08(c) 205.68(c) Last
        1 369 920 1 391 378 7 215 010 2 581 766 1 518 667 Volume
        -3.14% -0.29% +27.16% +1.74% +3.84% Change
        More quotes
        Financials (USD)
        Sales 2019 1 383 M
        EBIT 2019 92,6 M
        Net income 2019 35,4 M
        Finance 2019 303 M
        Yield 2019 -
        Sales 2020 1 631 M
        EBIT 2020 166 M
        Net income 2020 125 M
        Finance 2020 471 M
        Yield 2020 -
        P/E ratio 2019 383x
        P/E ratio 2020 114x
        EV / Sales2019 9,88x
        EV / Sales2020 8,27x
        Capitalization 13 962 M
        More Financials
        Company
        Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes and for use by healthcare providers. The Company's products consist of DexCom G4... 
        More about the company
        Surperformance© ratings of DexCom, Inc.
        Trading Rating : Investor Rating :
        More Ratings
        Latest news on DEXCOM, INC.
        11/08DEXCOM : Announces Upcoming Conference Presentation
        BU
        11/06DEXCOM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
        AQ
        11/06DEXCOM : 3Q Earnings Snapshot
        AQ
        11/06DEXCOM INC : Results of Operations and Financial Condition, Financial Statements..
        AQ
        11/06DEXCOM : Reports Third Quarter 2019 Financial Results
        BU
        11/01DEXCOM, INC. : quaterly earnings release
        10/09DEXCOM SCHEDULES THIRD QUARTER 2019 : 30 p.m. Eastern Time
        BU
        10/08DEXCOM : Announces FDA Clearance of New Dexcom G6 Pro CGM
        BU
        09/18DEXCOM INC : Change in Directors or Principal Officers, Other Events, Financial ..
        AQ
        09/17DEXCOM : Promotes Quentin Blackford to Chief Operating Officer
        BU
        09/17DEXCOM : Appoints Bridgette Heller to Board of Directors
        BU
        09/09DEXCOM : G6ョ CGM System Now Available In Canada
        AQ
        08/23DEXCOM : Court Rules that the Patents Asserted against Dexcom CGM Systems are In..
        BU
        08/02DEXCOM : Announces Upcoming Conference Presentations
        BU
        07/31DEXCOM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
        AQ
        More news
        News in other languages on DEXCOM, INC.
        11/01DEXCOM, INC. : publication des résultats trimestriels
        11/01DEXCOM, INC. : Veröffentlichung des Quartalsergebnisses
        2013DEXCOM, INC. : publication des résultats trimestriels
        2012DEXCOM, INC. : publication des résultats trimestriels
        More news
        Analyst Recommendations on DEXCOM, INC.
        More recommendations
        Sector news : Medical Equipment, Supplies & Distribution - NEC
        11/07Cardinal Health Posts 1Q Loss, Driven by Litigation Charges
        DJ
        11/05ZIMMER BIOMET : Third-Quarter Sales, Profit Beat Street Views
        DJ
        11/05GLOBAL MARKETS LIVE : ArcelorMittal, Adecco, Pandora, Samsung?/a>
        11/05BECTON DICKINSON AND : Swung to Profit in 4Q
        DJ
        11/04WRIGHT MEDICAL N : Shares Surge on Takeover by Stryker
        DJ
        More sector news : Medical Equipment, Supplies & Distribution - NEC
        Chart DEXCOM, INC.
        Duration : Period :
        DexCom, Inc. Technical Analysis Chart | MarketScreener
        Full-screen chart
        Technical analysis trends DEXCOM, INC.
        Short TermMid-TermLong Term
        TrendsBullishBullishBullish
        Income Statement Evolution
        Consensus
        Sell
        Buy
        Mean consensus BUY
        Number of Analysts 20
        Average target price 177,94  $
        Last Close Price 153,12  $
        Spread / Highest target 30,6%
        Spread / Average Target 16,2%
        Spread / Lowest Target -30,1%
        EPS Revisions
        Managers
        NameTitle
        Kevin Ronald Sayer Chairman, President & Chief Executive Officer
        Quentin S. Blackford Chief Operating & Financial Officer
        Andrew K. Balo EVP-Clinical, Regulatory Affairs & Quality
        Jacob Leach Chief Technology Officer
        Jay S. Skyler Independent Director
        Sector and Competitors
        1st jan.Capitalization (M$)
        DEXCOM, INC.71.69%13 962
        MEDTRONIC PLC18.69%143 384
        BAXTER INTERNATIONAL INC.19.81%40 012
        HOYA CORPORATION44.97%31 929
        ZIMMER BIOMET HOLDINGS38.18%29 458
        TERUMO CORPORATION-36.42%24 376
        bet9九州网址

            ,